SEC Form 4 · accession 0001104659-15-002963
NPS PHARMACEUTICALS INC · NPSP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael W Bonney
Director
Period of report
Jan 15, 2015
Accepted (ET)
Jan 16, 2015 · 3:35 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000890465
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Deferred Stock UnitsF1,F2 | — | Jan 15, 2015 | A | 384 | A | — | — | Common Stock | 384 | 167,608 | D |
Explanation of responses
- F1Each Deferred Stock Unit represents a right to receive one share of NPS Pharmaceuticals Inc.'s (the "Issuer") common stock.
- F2Deferred Stock Units are vested in full on the date of grant and will be settled in the Issuer's common stock upon (1) separation from service on the Board, (2) death, (3) disability or (4) a sale of substantially all the assets of the Issuer.